Skip to main content

Advertisement

Log in

Detection of HPV by in situ hybridization in thin-layer (ThinPrep) cervicovaginal samples

  • Research Article
  • Published:
Tumor Biology

Abstract

We have studied an automated in situ hybridization (ISH) method as a possible alternative approach for detecting high-risk human papillomavirus (HPV) in monolayer (ThinPrep) cervico-vaginal samples, comparing the results with those obtained by polymerase chain reaction (PCR) using consensus primers and studying the relationship between the ISH staining pattern and the viral integration in HPV 16-positive cases. Eighty atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesion (LSIL) cases were used for our purposes. The patients were monitored through periodic cytologies. ISH with was performed with an automated Ventana System, analysis by PCR was performed with consensus primers and integration of HPV16 was performed by realtime PCR analyzing E2 and E6 genes. Additionally, 27 HSIL cases were also studied to observe the ISH staining patterns. HPV infection was detected by ISH in 21.7% of the ASCUS cases and 55.8% of the LSIL cases. Two distinct staining patterns were observed: multipunctated (MP) and diffuse (DI). In some cases, a mixed pattern (MP + DI) was observed and these cases were considered as MP. The MP pattern increased with the degree of lesion and seemed to have a prognostic value in ASCUS/LSIL cases. The lesion in MP pattern cases persisted throughout the entire study in 77% of cases, whereas in cases with a DI staining pattern, only 41% of them showed persistence of the lesion (p < 0.001). No correlation was found between HPV integration and the ISH staining pattern. Given the lower sensitivity and negative predictive value of ISH and its incapacity to demonstrate the integration of high-risk HPV in ASCUS and LSIL cases using liquid-based cytology, we do not recommend this technique for the triage of ASCUS and LSIL cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. The Atypical Squamous Cells of Undetermined Significance/Low Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytology evidence of low-grade squamous intraepithelial lesions. Baseline data from a randomized trial. J Natl Cancer Inst. 2000;92(5):397–402.

    Article  Google Scholar 

  2. Ring M, Bolger N, O’Donell M, Malkin A, Bermingham N, Akpan E, et al. Evaluation of liquid-based cytology in cervical screening of high-risk populations: a split study of colposcopy and genito-urinary medicine populations. Cytopathology. 2002;13:152–9.

    Article  PubMed  CAS  Google Scholar 

  3. Schorge JO, Hossein Saboorian M, Hynan L, Ashfaq R. ThinPrep detection of cervical and endometrial adenocarcinoma. A retrospective cohort study. Cancer (Cancer Cytopathol). 2002;96:338–43.

    Google Scholar 

  4. Klinkhamer PJJM, Meerding WJ, Rosier PEWM, Hanselaar AGJM. Liquid- based cervical cytology. A review of the literature with methods of evidence-based medicine. Cancer (Cancer Cytopathol). 2003;99:263–71.

    Google Scholar 

  5. Bolick DR. Laboratory implementation of human papillomavirus testing. Arch Pathol Lab Med. 2003;127:984–90.

    PubMed  Google Scholar 

  6. Baunoch DA. In search of a paradigm: molecular and morphologic methods for human papillomavirus. Adv Adm Lab. 2001;10(5):1–10.

    Google Scholar 

  7. Hopman AHN, Theelen W, Hommelberg PPH, Kamps MAF, Herrington CS, Morrison LE, et al. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol. 2006;210:412–9.

    Article  PubMed  CAS  Google Scholar 

  8. Algeciras-Schmnich A, Policht F, Sitailo S, Song M, Morrison L, Sokolova I. Evaluation of quality and staining pattern of HPV infected epithelial cells in thin-layer cerviucal specimens using optimized HPV-Card assay. Cancer (Cancer Cytopathol). 2007;111:330–8.

    Google Scholar 

  9. Cavuslu S, Mant C, Starkey WG, Bible JM, Biswas C, Kell B, et al. Analytic sensitivities of hybrid-capture, consensus and type-specific polymerase chain reactions for the detection of human papillomavirus type 16DNA. J Med Virol. 1996;49(4):319–24.

    Article  PubMed  CAS  Google Scholar 

  10. Vernon SD, Unger ER, Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line brotting, and hybrid capture. J Clin Microbiol. 2000;38(2):651–5.

    PubMed  CAS  Google Scholar 

  11. Kosel S, Burggraf S, Mommsen J, Engelhardt W, Olgemoller B. Type-specific detection of human papillomaviruses in a routine laboratory setting-improved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisation. Clin Chem Lab Med. 2003;41(6):787–91.

    Article  PubMed  Google Scholar 

  12. Nuovo GJ. Detection of human papillomavirus in papanicolau smears: correlation with pathologic findings and clinical outcome. Diagn Mol Pathol. 1998;7(3):158–63.

    Article  PubMed  CAS  Google Scholar 

  13. Layfiel LJ, HPV QN. DNA, testing in the triage of atypical squamous cells of undetermined significance (ASCUS). Cost comparison of two methods. Diagn Cytopathol. 2005;33(2):138–43.

    Article  Google Scholar 

  14. Qureshi MN, Rudelli RD, Tubbs RR, Biscotti CV, Layfield LJ. Role of HPV DNA testing in predicting cervical intraepithelial lesions: comparison of HC HPV and ISH HPV. Diagn Cytopathol. 2003;29:149–55.

    Article  PubMed  Google Scholar 

  15. Quredshi MN, Bolick D, Ringer PJ, Spagler FL, Zimmerman G. HPV testing in liquid cytology specimens: comparison of analytic sensitivity and specificity for in situ hybridization and chemiluminescent nucleic acid testing. Acta Cytol. 2005;49(2):120–6.

    Article  Google Scholar 

  16. Stoler MH. HPV testing in cervical cytology practice. It’s all about choice. Acta Cytol. 2005;49:117–9.

    Article  PubMed  Google Scholar 

  17. Evans MF, Mount SL, Beatty BG, Cooper K. Biotinyl-tyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical lntraepithelial neoplasia. Mod Pathol. 2002;15(12):1339–47.

    Article  PubMed  Google Scholar 

  18. Birner P, Bachtiary B, Dreier B, Schindi M, Joura EA, Breitenecker G, et al. Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions. Mod Pathol. 2001;14(7):702–9.

    Article  PubMed  CAS  Google Scholar 

  19. Sano T, Hikino T, Niwa Y, Kashiwabara K, Oyama T, Pukuda T, et al. In situ hybridization with biotinylated tyramide amplification: detection of human papillomavirus DNA in cervical neoplastic lesions. Mod Pathol. 1998;11(1):19–23.

    PubMed  CAS  Google Scholar 

  20. Nasar Qureshi M, Rudelli RD, Ringer P. Analysis of HPV in situ hybridization assay (INFORM HPV, Ventana Medical Systems Inc.) by the automated cellular imaging systems ACIS (ChromaVision Medical Systems Inc). Poster accepted for presentation in 2003 USCAP.

  21. Tjalma WA, Wan Waes TR, Van den Eeden LE, Bogers JJ. Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol. 2005;19(4):469–83.

    Article  PubMed  CAS  Google Scholar 

  22. Gallo G, Bibbo M, Bagella L, Zamparelli A, Sanseverino F, Giovanoli MR, et al. Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol. 2003;56(7):532–6.

    Article  PubMed  CAS  Google Scholar 

  23. Hopman AH, Kamps MA, Smedts F, Speel EJ, Herrington CS, Ramaekers FC. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV. Int J Cancer. 2005;115(3):419–28.

    Article  PubMed  CAS  Google Scholar 

  24. Guo M, Gong Y, Deavers M, Silva ES, Jan YJ, Cogdell DE, et al. Evaluation of commercialized in situ hybridization assay for detecting HPB DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma. J Clin Microbiol. 2008;46(1):274–80.

    Article  PubMed  CAS  Google Scholar 

  25. De Marchi Triglia R, Metze K, Zeferino LC, de Lucci de Angelo Andrade LA. HPV in situ hibridization signal patterns as a marker for cervical intraepithelial neoplasia progression. Gynecol Oncol. 2009;112:114–8.

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesc Alameda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alameda, F., Mariñoso, M.L., Bellosillo, B. et al. Detection of HPV by in situ hybridization in thin-layer (ThinPrep) cervicovaginal samples. Tumor Biol. 32, 603–609 (2011). https://doi.org/10.1007/s13277-011-0159-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-011-0159-4

Keywords

Navigation